EUR/USD to Fall to 1.15 By Year-End, Sterling to Rise, Says BNP
Paribas Markets 360
BNP Paribas Markets 360 expects the U.S. dollar to strengthen
versus low-beta currencies and forecasts EUR/USD to fall to 1.15 by
the end of the year, from 1.1826 currently. The dollar is likely to
weaken against high-beta currencies, however, G10 FX strategist
Parisha Saimbi says in a webinar. BNP Paribas Markets 360's top
pick is sterling as it expects the Bank of England to be "much more
responsive to the economic upswing than the European Central Bank,"
she says.
Companies News:
Panoply Shares Rise as Five-Month Performance Tops
Expectations
Shares in Panoply Holdings PLC rose sharply on Wednesday after
it said business was significantly ahead of expectations for the
first five months of its fiscal year and raised its guidance for
the year.
---
Restore Says 3Q Marked By Positive Trading Momentum
Restore PLC has backed its growth target for the year after
positive trading momentum so far in the third quarter.
---
Actual Experience Appoints Kirsten English as Chairwoman
Actual Experience PLC said Wednesday that Kirsten English will
replace Chairman Stephen Davidson, who will retire after the
company's next annual general meeting in March.
---
Fintel Signs Fintech, Distribution Agreement With Tatton; Sells
Verbatim for GBP5.8 Mln
Fintel PLC said Wednesday that it has signed a fintech and
distribution agreement with Tatton Asset Management PLC, which
includes the sale of Verbatim, its fund management business, for a
cash consideration of up to 5.8 million pounds ($8 million).
---
Renewables Infrastructure Group to Raise GBP200 Mln
Renewables Infrastructure Group Ltd. said on Wednesday that it
will raise 200 million pounds ($276.9 million) by issuing about
161.3 million ordinary shares.
---
TinyBuild Posts Lower 1H Pretax Profit
Videogames company tinyBuild Inc. said Wednesday that pretax
profit for the first half of the year fell on one-off costs, as it
acquired Russian development studio Bad Pixel.
---
Science in Sport Booked 1H Pretax Loss; 2H Started With Strong
Sales
Science in Sport PLC said Wednesday that it booked a pretax loss
in the first six months of 2021, while sales were dynamic in July
and August.
---
HgCapital Trust Agrees to Sell Achilles to Bridgepoint
HgCapital Trust PLC said Wednesday that it has agreed to sell
its supply-chain risk and performance management company Achilles
to Bridgepoint Group PLC for an undisclosed sum.
---
Cake Box Holdings CFO Sells GBP1.3 Mln Stake in Company
Cake Box Holdings PLC said Wednesday that Chief Financial
Officer Pardip Dass has sold a stake in the company worth 1.3
million pounds ($1.8 million).
---
Central Asia Metals Raises Dividend as Commodity Prices Boost 1H
Profit -- Update
Central Asia Metals PLC on Wednesday reported an improved profit
for the first half and raised its interim dividend.
---
Pentair to Buy Filter Maker Pleatco for $255 Million >PNR
Pentair PLC on Wednesday said it agreed to buy Pleatco, a maker
of water-filtration and clean-air technologies for pool, spa and
industrial air customers, from private-equity firm Align Capital
Partners for about $255 million in cash.
---
eEnergy to Buy UtilityTeam for Up to GBP21 Mln, Launches Share
Placing
eEnergy Group PLC said Wednesday that it intends to acquire U.K.
energy-management company UtilityTeam for up to 21 million pounds
($29 million) and raise GBP12 million in a share placing to partly
fund the purchase.
---
U.K. Online Car Retailer Cazoo Buys SMH Fleet Solutions
U.K. online car retailer Cazoo Group Ltd. said it acquired SMH
Fleet Solutions, a vehicle preparation, logistics and storage
company.
Market Talk:
Fevertree 1H Profit Rises, But Costs, Supply Woes Weigh
0941 GMT - Fevertree Drinks gains 1% after the mixer-maker
reported higher first-half pretax profit, though rising costs and
supply issues weighed. Fevertree sales have benefited from the
re-opening of bars and continued strong sales in shops and
supermarkets, Hargreaves Lansdown says. "However, like many
businesses, Fevertree has had to contend with rising logistics
costs--especially in shipping product across the Atlantic," HL
analyst Nicholas Hyett says. "With input costs also rising and
heavy-goods vehicle shortages creating some bottlenecks, disruption
could get worse before it gets better. New bottling partners across
the pond will help reduce the headwind next year, but in the short
term, it's weighing on margins and means profit growth has been
slower."
---
Fevertree's Margin Outlook to Cause 2022 Consensus
Downgrades
0946 GMT - Fevertree's first-half results were unsurprising but
its relatively cautious stance on margin improvement in 2022 is
likely to bring down consensus forecasts, Citi says. The drinks
manufacturer said it expects a marginal improvement in its Ebitda
margin. Citi says consensus forecasts currently assume a
140-basis-point improvement, so the guidance is set to cause a
low-single-digit cut to consensus earnings per share forecasts. "We
don't see the results today as a catalyst for the shares'
performance to improve near-term. We continue to think that further
share price outperformance relies on Fevertree delivering ahead of
the sales guidance," Citi says.
---
Tullow Oil Still a Sell Despite Progress, Panmure Says
0956 GMT - Tullow Oil is moving forward, but there is more to
do, says Panmure Gordon after the Africa-focused oil producer
reported a first-half profit and narrowed 2021 production guidance
toward the upper end of its range. While early signs of progress
from its new strategy are encouraging, FTSE 250-listed Tullow
remains a long way from restoring the dividend and offering the
growth potential investors typically seek from exploration and
production companies, Panmure says. "The company is fully valued at
current levels and there are numerous better alternatives for
investors seeking exposure to the E&P sector," Panmure analyst
Ashley Kelty says, increasing the brokerage's target price to 45
pence from 44 pence, but reiterating its sell recommendation.
Shares rise 7% to 48 pence.
---
Renalytix Shares Fall on Medicare Decision But Concerns Seen as
Unwarranted
1054 GMT - Renalytix shares trade lower following the U.S.
Centers for Medicare & Medicaid Services decision to repeal the
Medicare Coverage of Innovative Technology rule that could allow
for Medicare providing FDA-approved breakthrough devices. But the
decision shouldn't affect adoption of the diagnostics group's
KidneyIntelX technology for several reasons, Berenberg says.
Clinical studies show Renalytix's KidneyIntelX has improved patient
outcomes, more than $1 billion in savings could be achieved using
it over the current standard of care, and it's proven a valuable
diagnostic tool, the German brokerage's analyst Anita Dushyanth
says. "While we acknowledge that FDA safety and effectiveness
standards alone are insufficient to support open-ended Medicare
coverage, we do not envision risk to our revenue ramp at this
time," Dushyanth says. Shares are down 12% at 680.0 pence.
---
Central Asia Metals Shares Rise as Dividend Exceeds
Expectations
1100 GMT - Shares in Central Asia Metals rise 5.8% after
increasing the interim dividend to 8 pence and reporting first-half
results. The dividend payment is the highlight of the earnings
statement, as it was well above expectations of 6 pence, Berenberg
says. Elsewhere, the German bank points out that CAM has been
active on the business development front and reviewed 18
opportunities in the first half. "No advanced discussions are under
way currently, and this is likely reflective of differing views on
asset valuations; still, it shows that management is considering
growth but is being disciplined in capital allocation," Berenberg
says. The bank has a buy rating on the mining company.
---
Pan African Resources Sparkles After Dividend, Buyback
1223 GMT - Shares in Pan African Resources rise 3.7% to 335
pence after the gold miner reported a record profit for fiscal 2021
on the back of higher production. The company reported higher 2H
costs, but said cash flows were still in line, as forecast in EPS
guidance issued last week, Peel Hunt says. However, PAF also
increased dividends and announced a share buyback program, the
brokerage says. The coming year looks to be the period when PAF
intends to start achieving shareholder value, Peel Hunt analysts
say.
---
BOE Could Still Make Case for Pushing Back Cutting Stimulus
1256 GMT - The Bank of England could delay tightening monetary
policy as long as inflation expectations remain contained, says
Nomura. "Should they [inflation expectations] remain contained then
it would be easier to make the case for holding back policy
tightening," says chief UK & euro area economist George
Buckley. He sees risks to the bank's view that the BOE may raise
interest rates for the first time in February 2023, the risk of
another wave of the virus and associated restrictions could still
mean the near 40 basis points of tightening assumed by the market
over the next year is too aggressive, he adds.
Contact: London NewsPlus, Dow Jones Newswires; Write to Sarka
Halas at sarka.halas@wsj.com
(END) Dow Jones Newswires
September 15, 2021 09:36 ET (13:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
FTSE 100
Index Chart
From Aug 2024 to Sep 2024
FTSE 100
Index Chart
From Sep 2023 to Sep 2024